These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23751076)

  • 1. Genome variation and personalized cancer medicine.
    Hudson TJ
    J Intern Med; 2013 Nov; 274(5):440-50. PubMed ID: 23751076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future perspectives of personalized oncology.
    Stambuk S; Sundov D; Kuret S; Beljan R; Andelinović S
    Coll Antropol; 2010 Jun; 34(2):763-9. PubMed ID: 20698168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and familial factors influencing breast, colon, prostate and lung cancers.
    Stein QP; Flanagan JD
    S D Med; 2010; Spec No():16-22. PubMed ID: 20397487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer screening. Genetic analysis points the way to individualized PSA tests.
    Couzin-Frankel J
    Science; 2010 Dec; 330(6011):1602. PubMed ID: 21163976
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing prostate cancer therapy: the way forward.
    Cetnar JP; Beer TM
    Drug Discov Today; 2014 Sep; 19(9):1483-7. PubMed ID: 25046532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of low-penetrance alleles associated with colon cancer risk].
    Houlston R
    Med Sci (Paris); 2009 Mar; 25 Spec No 1():39-41. PubMed ID: 19361410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in cancer: personalizing diagnosis and therapy.
    Nana-Sinkam SP; Fabbri M; Croce CM
    Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic medicine frontier in human solid tumors: prospects and challenges.
    Dienstmann R; Rodon J; Barretina J; Tabernero J
    J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
    Watson AP; Egland KA
    S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited susceptibility to common cancers.
    Foulkes WD
    N Engl J Med; 2008 Nov; 359(20):2143-53. PubMed ID: 19005198
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
    Gandellini P; Folini M; Zaffaroni N
    Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer management: opportunities and barriers to an individualized approach.
    Perez EA
    Oncologist; 2011; 16 Suppl 1():20-2. PubMed ID: 21278437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized treatment of early-stage breast cancer: present concepts and future directions.
    Harbeck N; Salem M; Nitz U; Gluz O; Liedtke C
    Cancer Treat Rev; 2010 Dec; 36(8):584-94. PubMed ID: 20554119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.